OgilvyOne HK wins Interhealthtechnology

<p>OgilvyOne Hong Kong has been appointed by Interhealthtechnology, a </p><p>division of major pharmaceutical distributor Zuellig Pharma, for a </p><p>360-degree brand building campaign across six markets (Hong Kong, </p><p>Philippines, Malaysia, Singapore, Korea and Taiwan). </p><p><BR><BR> </p><p>OgilvyOne Hong Kong MD Chris Riley said the agency would help the client </p><p>develop Asia's first major online pharmaceutical procurement </p><p>offering. </p><p><BR><BR> </p><p>OgilvyOne's first task is to launch AsiaRx, an online pharmaceutical </p><p>marketplace, in four markets. </p><p><BR><BR> </p><p>In preparation for the launch, OgilvyOne is carrying out market research </p><p>as the backbone of AsiaRx's brand positioning and customer value </p><p>proposition. </p><p><BR><BR> </p><p>Ogilvy's planning team, OgilvyAsiaNet and MindShare are also involved. </p><p><BR><BR> </p>

OgilvyOne Hong Kong has been appointed by Interhealthtechnology, a

division of major pharmaceutical distributor Zuellig Pharma, for a

360-degree brand building campaign across six markets (Hong Kong,

Philippines, Malaysia, Singapore, Korea and Taiwan).



OgilvyOne Hong Kong MD Chris Riley said the agency would help the client

develop Asia's first major online pharmaceutical procurement

offering.



OgilvyOne's first task is to launch AsiaRx, an online pharmaceutical

marketplace, in four markets.



In preparation for the launch, OgilvyOne is carrying out market research

as the backbone of AsiaRx's brand positioning and customer value

proposition.



Ogilvy's planning team, OgilvyAsiaNet and MindShare are also involved.